Healthcare /
Ferrosan Medical Devices

Responsible partner

Fredrik Strömholm

Industry

MedTech

2014 turnover

EUR ~40 million

No. of employees

~185

CEO

Henrik Krøis

Acquisition date

2011

Exit date

2016

FMD is a world leading provider of gelatine-based absorbable haemostatic products. Key products are Spongostan® / Surgifoam® (a gelatine-based absorbable haemostat also offered in powder form) and Surgiflo® (a prefilled, flowable haemostat). The company, including production, is located in Søborg outside Copenhagen.